Bionano Genomics Stock News

Why these three penny stocks are pushing up right now The post Best Penny Stocks to Buy on Friday the 13th? 3 to Watch Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyS

Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -37.50% and 5.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

The risks may be clear when it comes to Bionano Genomics and BNGO stock. However, investors should see this as a long-term play.

Bionano Genomics, Inc. (BNGO) CEO Erik Holmlin at 2nd Annual Maxim Group Virtual Growth Conference (Transcript)

SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. ( BNGO ), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ software, the le

Bionano Genomics is working hard to address rare diseases, yet Wall Street doesn't see the value in BNGO stock -- but that could change soon. The post Bionano Genomics Stock Can Regain the Crucial $5

Three strategies for trading penny stocks in 2022 The post How to Invest in Penny Stocks in 2022, 3 Strategies to Use  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks

If you're willing to endure a slow start, it might be a great stock to own down the line.

BNGO stock has been a falling knife for the past year. But, with promising fundamentals and good tailwinds, now be the time to take a chance.

Check these 3 penny stocks out after a recent death cross pattern The post Is the Death Cross a Positive for Penny Stocks? 3 to Watch  appeared first on Penny Stocks to Buy, Picks, News and Informati

Here's three penny stocks to watch after a solid day of trading The post 3 Penny Stocks to Watch After the Best Trading Day in Almost 2 Years appeared first on Penny Stocks to Buy, Picks, News and Inf

SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr ® system and provider of N x Clinical™, a leading software solution for visualization, interpretation, and reporting of genomic data, announced today that company management will present virtually at the 32 nd Annual Oppenheimer Healthcare Conference. Erik Holmlin, PhD, Bionano’s president and chief executive officer, is scheduled to present a corporate overview on Tuesday, March 15th, 2022 at 5:40 am PT/8:40 am ET.

SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, a leading softwar

We all know the story by now. A once high-flying stock presently sits at a level far below a previously attained peak. And so it is with Bionano (BNGO). The

Read more